ALLK (Allakos) Short-Term Debt to Capital
The price trajectory of Allakos Inc. (ALLK) on the GURU.Markets platform demonstrates the 0.00 indicator. Allakos Inc. (ALLK) is implementing automated stations for accelerated antibody analysis to optimize the preclinical stage. The business develops anti-inflammatory and anti-allergy drugs for the dermatological and gastroenterological segments. Within the scientific community, the brand is valued for its innovative method of managing mast cells in severe pathologies.
Analytical breakdowns for Allakos Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:Allakos
This ratio determines the share of short-term liabilities within the net capital structure, allowing investors to use the short-term debt-to-equity ratio to promptly monitor liquidity risks and shifts in financing strategy, which is critically important for Allakos Inc. (ALLK), whose valuation is based on long-term antibody development and expected payments from insurance funds.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|SEPN - Short-Term Debt to Capital|Pieris Pharmaceuticals (PVLA) - Short-Term Debt to Equity|SVRA (savarapharma.com) - Short-Term Debt to Equity|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|Short-Term Debt to Equity ANAB|Short-Term Debt to Capital ATXS|Short-Term Debt to Capital enGene Corp (ENGN)|Short-Term Debt to Equity RAPT Therapeutics RAPT|Short-Term Debt to Capital Aerovate Therapeutics, Inc. JBIO|ACRS - Short-Term Debt to Equity|Current Liabilities to Capital Kyverna Therapeutics Inc.|Tiziana Life Sciences PLC (TLSA) - Short-Term Debt to Equity|CABA - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio VTYX|THTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AVTX|Short-Term Debt to Capital Coefficient Eledon Pharmaceuticals Inc.|Short-Term Debt to Equity Agenus Inc AGEN|CLYM: Short-Term Debt to Capital Ratio|Zura Bio - Short-Term Debt to Capital|atyrpharma.com (ATYR) - Short-Term Debt to Equity Ratio|ADAG (adagene.com) - Short-Term Debt to Equity Ratio|IMA - Short-Term Debt to Capital Coefficient|STTK (Shattuck Labs Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital Equillium Bio|Short-Term Debt to Equity Connect Biopharma (CNTB)|Short-Term Debt to Equity IMUX (immunic-therapeutics.com)|Short-Term Debt to Equity Atara Bio ATRA|InflaRx NV - Short-Term Debt to Equity|XFOR - Short-Term Debt to Equity|ACET - Short-Term Debt to Capital|celularity.com (CELU) - Short-Term Debt to Equity|Current Liabilities to Equity INMB (inmunebio.com)|BRNS (Barinthus Biotherapeutics plc) - Short-Term Debt to Capital|KZR: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital SABS|Short-Term Debt to Capital Akari Therapeutics, Plc (AKTX)|Short-Term Debt to Equity Enlivex Therapeutics Ltd. ENLV|Ratio of Short-Term Indebtedness to Capital QTTB|GOVX - Short-Term Debt to Equity|Edesa Biotech Inc (EDSA) - Short-Term Debt to Equity Ratio|IBIO: Short-Term Debt to Capital|Carisma Therapeutics Inc. (CARM) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio XTLB|BOLT: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital HCWB|Short-Term Debt to Capital Coefficient aptevotherapeutics.com|Short-Term Debt to Equity AIM ImmunoTech Inc. AIM|ADTX - Short-Term Debt to Equity Ratio|GRI - Short-Term Debt to Equity|xortx.com (XRTX) - Short-Term Debt to Equity Ratio|HIND (Vyome Holdings) - Short-Term Debt to Equity Ratio|Revelation Biosciences Inc (REVB) - Short-Term Debt to Capital|Short-Term Debt to Equity Indaptus|Short-Term Debt to Capital Ratio SCNI (BiondVax Pharmaceuticals)|Short-Term Debt to Capital CALI|AFMD - Current Liabilities to Capital|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|ITOS - Short-Term Debt to Equity|OCEA: Short-Term Debt to Equity|TC Biopharm (TCBP) - Short-Term Debt to Equity|THRD (thirdharmonicbio.com) - Short-Term Debt to Equity